• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pulmonary aspergillosis: a clinical review.肺曲霉病:临床综述。
Eur Respir Rev. 2011 Sep 1;20(121):156-74. doi: 10.1183/09059180.00001011.
2
Advances in the diagnosis and management of pulmonary aspergillosis.肺曲霉病诊断与管理的进展
Adv Respir Med. 2019;87(6):231-243. doi: 10.5603/ARM.2019.0061.
3
Allergic aspergillosis of the respiratory tract.呼吸道变应性曲霉菌病
Eur Respir Rev. 2014 Mar 1;23(131):8-29. doi: 10.1183/09059180.00007413.
4
The clinical spectrum of pulmonary aspergillosis.肺部曲霉菌病的临床谱。
Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29.
5
Pulmonary Aspergillosis: What the Generalist Needs to Know.肺曲霉病:全科医生应知应会
Am J Med. 2020 Jun;133(6):668-674. doi: 10.1016/j.amjmed.2020.02.025. Epub 2020 Mar 30.
6
The spectrum of pulmonary aspergillosis.肺部曲霉菌病的光谱。
Respir Med. 2018 Aug;141:121-131. doi: 10.1016/j.rmed.2018.06.029. Epub 2018 Jul 3.
7
High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.从慢性真菌病患者肺部的不可培养烟曲霉中发现高频三唑耐药性。
Clin Infect Dis. 2011 May;52(9):1123-9. doi: 10.1093/cid/cir179.
8
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.囊性纤维化患儿肺曲霉病的临床表现——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):66-79.
9
Manifestations of pulmonary aspergillosis in pediatrics.儿童肺曲霉病的表现。
Curr Opin Pediatr. 2020 Jun;32(3):389-394. doi: 10.1097/MOP.0000000000000898.
10
[Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].[曲霉相关的呼吸道疾病与慢性阻塞性肺疾病:诊断挑战]
Rev Mal Respir. 2020 Apr;37(4):308-319. doi: 10.1016/j.rmr.2020.02.011. Epub 2020 Apr 10.

引用本文的文献

1
Native lung aspergilloma after single lung transplantation-a case series.单肺移植术后原发性肺曲菌球——病例系列
J Thorac Dis. 2025 Aug 31;17(8):5883-5892. doi: 10.21037/jtd-2025-283. Epub 2025 Aug 15.
2
Pulmonary Aspergillosis Mimicking Metastatic RCC: A Postnephrectomy Diagnostic Consideration.酷似转移性肾细胞癌的肺曲霉病:肾切除术后的诊断考量
Case Rep Med. 2025 Sep 5;2025:9920083. doi: 10.1155/carm/9920083. eCollection 2025.
3
Managing Invasive Fungal Infections During Allogeneic Hematopoietic Transplantation: A 2025 Update.异基因造血移植期间侵袭性真菌感染的管理:2025年更新
Mediterr J Hematol Infect Dis. 2025 Sep 1;17(1):e2025064. doi: 10.4084/MJHID.2025.064. eCollection 2025.
4
Successful Treatment of Aspergilloma With Antifungal Alone: A Case of Conservative Management.仅用抗真菌药物成功治疗曲菌球:一例保守治疗病例
Respirol Case Rep. 2025 Aug 27;13(8):e70334. doi: 10.1002/rcr2.70334. eCollection 2025 Aug.
5
Pulmonary Aspergilloma in a Non-adherent Systemic Lupus Erythematosus Patient Receiving Long-Term Immunosuppression: A Report of a Rare Case.一名接受长期免疫抑制治疗的非粘连性系统性红斑狼疮患者发生肺曲菌球:1例罕见病例报告
Cureus. 2025 Jul 28;17(7):e88925. doi: 10.7759/cureus.88925. eCollection 2025 Jul.
6
Emerging Risk Factors for Invasive Pulmonary Aspergillosis: A Narrative Review.侵袭性肺曲霉病的新兴危险因素:一项叙述性综述
J Fungi (Basel). 2025 Jul 27;11(8):555. doi: 10.3390/jof11080555.
7
Aspergillosis: A comprehensive review of pathogenesis, drug resistance, and emerging therapeutics.曲霉病:发病机制、耐药性及新兴治疗方法的全面综述
J Food Drug Anal. 2025 Jun 13;33(2):75-96. doi: 10.38212/2224-6614.3547.
8
Diagnosis of invasive pulmonary aspergillosis using metagenomic next-generation sequencing and conventional microbial tests post-COVID-19 pandemic.在新冠疫情后使用宏基因组下一代测序和传统微生物检测诊断侵袭性肺曲霉病
Microbiol Spectr. 2025 Jul;13(7):e0012125. doi: 10.1128/spectrum.00121-25. Epub 2025 Jun 9.
9
Chronic Cavitary Pulmonary Aspergillosis.慢性空洞性肺曲霉病
Open Respir Arch. 2025 Apr 3;7(3):100436. doi: 10.1016/j.opresp.2025.100436. eCollection 2025 Jul-Sep.
10
Development of Voriconazole Proliposome Based Dry Powder for Inhalation: A Design of Experiment Approach.伏立康唑前体脂质体吸入用干粉的研制:一种实验设计方法。
Pharmaceutics. 2025 May 8;17(5):622. doi: 10.3390/pharmaceutics17050622.

本文引用的文献

1
An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.美国胸科学会官方声明:成人肺部和重症监护患者真菌感染的治疗。
Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128. doi: 10.1164/rccm.2008-740ST.
2
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis.肺曲菌球与变应性支气管肺曲霉菌病的关联。
Eur Respir Rev. 2010 Dec;19(118):349-51. doi: 10.1183/09059180.00004810.
3
Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?变应性支气管肺曲霉病与曲菌球并存:这是一种更严重的疾病形式吗?
Eur Respir Rev. 2010 Dec;19(118):261-3. doi: 10.1183/09059180.00009010.
4
Allergic bronchopulmonary aspergillosis.变应性支气管肺曲霉病。
Proc Am Thorac Soc. 2010 May;7(3):237-44. doi: 10.1513/pats.200908-086AL.
5
Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.支气管肺泡灌洗半乳甘露聚糖对侵袭性肺曲霉病高危患者预后的影响
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S86-93.
6
Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.支气管肺泡灌洗液半乳甘露聚糖检测有助于血液科患者侵袭性肺曲霉病的诊断。
BMC Infect Dis. 2010 Mar 3;10:44. doi: 10.1186/1471-2334-10-44.
7
Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis.支气管哮喘患者中的曲霉超敏反应和变应性支气管肺曲霉病:系统评价和荟萃分析
Int J Tuberc Lung Dis. 2009 Aug;13(8):936-44.
8
Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases.孤立性侵袭性曲霉菌气管支气管炎:19 例临床研究。
Clin Microbiol Infect. 2010 Jun;16(6):689-95. doi: 10.1111/j.1469-0691.2009.02923.x. Epub 2009 Aug 18.
9
Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages.香烟烟雾调节人巨噬细胞 TLR4 的表达和 IL-8 的产生。
J Inflamm (Lond). 2009 May 1;6:12. doi: 10.1186/1476-9255-6-12.
10
Noninvasive pulmonary Aspergillus infections.非侵袭性肺曲霉感染
Clin Chest Med. 2009 Jun;30(2):315-35, vii. doi: 10.1016/j.ccm.2009.02.008.

肺曲霉病:临床综述。

Pulmonary aspergillosis: a clinical review.

机构信息

Division of Pulmonary Critical Care and Sleep Medicine, Wayne State University School of Medicine, Harper University Hospital, 3990 John R, Detroit, MI 48201, USA.

出版信息

Eur Respir Rev. 2011 Sep 1;20(121):156-74. doi: 10.1183/09059180.00001011.

DOI:10.1183/09059180.00001011
PMID:21881144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9584108/
Abstract

Aspergillus is a mould which may lead to a variety of infectious, allergic diseases depending on the host's immune status or pulmonary structure. Invasive pulmonary aspergillosis occurs primarily in patients with severe immunodeficiency. The significance of this infection has dramatically increased with growing numbers of patients with impaired immune state associated with the management of malignancy, organ transplantation, autoimmune and inflammatory conditions; critically ill patients and those with chronic obstructive pulmonary disease appear to be at an increased risk. The introduction of new noninvasive tests, combined with more effective and better-tolerated antifungal agents, has resulted in lower mortality rates associated with this infection. Chronic necrotising aspergillosis is a locally invasive disease described in patients with chronic lung disease or mild immunodeficiency. Aspergilloma is usually found in patients with previously formed cavities in the lung, whereas allergic bronchopulmonary aspergillosis, a hypersensitivity reaction to Aspergillus antigens, is generally seen in patients with atopy, asthma or cystic fibrosis. This review provides an update on the evolving epidemiology and risk factors of the major manifestations of Aspergillus lung disease and the clinical manifestations that should prompt the clinician to consider these conditions. Current approaches for the diagnosis and management of these syndromes are discussed.

摘要

曲霉菌是一种霉菌,根据宿主的免疫状态或肺部结构,可能会引发多种感染和过敏疾病。侵袭性肺曲霉病主要发生在严重免疫功能低下的患者中。随着越来越多的恶性肿瘤、器官移植、自身免疫和炎症性疾病患者免疫状态受损的患者数量的增加,这种感染的重要性显著增加;危重症患者和慢性阻塞性肺疾病患者的风险似乎更高。新的非侵入性检测方法的引入,加上更有效和耐受性更好的抗真菌药物,导致与这种感染相关的死亡率降低。慢性坏死性曲霉病是一种局部侵袭性疾病,见于慢性肺部疾病或轻度免疫功能低下的患者。曲霉菌球通常发生在肺部先前形成空洞的患者中,而变应性支气管肺曲霉病是对曲霉抗原的过敏反应,一般见于特应性、哮喘或囊性纤维化患者。这篇综述介绍了曲霉肺病主要表现形式的流行病学和危险因素的最新进展,以及应促使临床医生考虑这些情况的临床表现。讨论了这些综合征的诊断和管理的最新方法。